Potentials of contemporary biomarkers in assessing skin lesions and fibrous activity in systemic scleroderma

Abstract

Systemic scleroderma (SSD) is a systemic disease with heterogeneous clinical manifestations of skin and internal organs lesions. It is believed that the trigger for its development is the initial damage of the blood vessels leading to an inflammatory reaction and accumulation of collagen and other extracellular matrix components. One of the important aspects of managing these patients is the identification of patients with a high risk of internal organ and skin damage and control of fibrotic activity in response to therapy. Diagnosis and control of skin lesions in SSD is performed by clinical observation and the use of methods such as skin count on the Rodnan scale (mRSS), durometry, goniometry, and ultrasonic skin thickness determination. However, the sensitivity of these methods is quite low, they are not validated for use at present and are rather laborious and subjective. In addition, these methods do not provide information about the fibrotic activity. These disadvantages of the above mentioned methods can be compensated by studying the biomarkers of skin lesions in SSD which reflect not only the inflammatory and fibrotic activity, but also can be used for evaluating the prognosis and effectiveness of the treatment. This review focuses on biomarkers of skin lesions in patients with scleroderma. These include the growth factors, cytokines and proteases, their inhibitors, as well as some proteins of the extracellular matrix, especially collagens, which were identified in skin biopsies and in serum samples of patients with SSD. The review summarizes non­invasive physical and laboratory studies that provide a better understanding of the fibrotic activity of the disease, can be effectively used to evaluate a potential therapeutic response and find best treatment options for patients with SSD.

Authors and Affiliations

I. Yu. Golovach, Ye. D. Yehudina

Keywords

Related Articles

The use of plasma enriched with platelets and fractional CO2 laser for the treatment of post-­acne

Objective — to develop a comprehensive method for restoring facial skin with post­acne symptoms. Materials and methods. From 2015 till 2016 there were 30 patients with post­acne symptoms under our supervision. Of these,...

Investigation of the impact of Prostrolane Natural-B on the main pathogenetic links of inflammatory skin aging

Objective — to investigate the effectiveness of Prostrolane Natural-B (injectable biorevitalizant with filling effect) in patients with age-related skin changes based on the dynamics of immunohistochemical markers of inf...

Modern approaches to optimization of external therapy of pityriasis versicolor

According to different authors up to 10 % of the world population suffer from pityriasis versicolor. Considering the tendency to an increase in the incidence of this dermatosis, a change in the virulence of the pathogen,...

Onychomycosis: prevalence, peculiarities of the course and possibilities of therapy at present stage in Ukraine

The analysis of statistical data on detection of onychomycosis pathogens in the clinical diagnostic laboratory of the regional dermatovenerologic dispensary of the city of Dnipro from 2014 to 2018 and the Center of Labor...

Soap Perolite in treatment of acne

The data are presented of the clinical study of the effectiveness of soap with the brand name Perolite, which includes benzoyl peroxide, and Perolite plus containing benzoyl peroxide and clindamycin for the local treatme...

Download PDF file
  • EP ID EP672781
  • DOI 10.30978/UJDVK2019-3-113
  • Views 60
  • Downloads 0

How To Cite

I. Yu. Golovach, Ye. D. Yehudina (2019). Potentials of contemporary biomarkers in assessing skin lesions and fibrous activity in systemic scleroderma. Український журнал дерматології, венерології, косметології, 0(3), 113-123. https://europub.co.uk/articles/-A-672781